Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Casper Steenholdt

Showing results (1-10 of 82) with videos related to

Pageof 9
Sort By:
The American Journal of Gastroenterology|December 1, 2015
Transient and Persistent Antibodies Against TNF-Inhibitors in IBDCasper Steenholdt
Danish Medical Journal|August 2, 2016
Personalized therapy with TNF-inhibitors in Crohn's disease: optimizing treatment outcomes by monitoring drug levels and anti-drug antibodiesCasper Steenholdt
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 21, 2018
Proactive and Reactive Therapeutic Drug Monitoring of Biologic Therapies in Inflammatory Bowel Disease Are Complementary, Not Mutually ExclusiveCasper Steenholdt
Danish Medical Journal|May 9, 2013
Use of infliximab and anti-infliximab antibody measurements to evaluate and optimize efficacy and safety of infliximab maintenance therapy in Crohn's diseaseCasper Steenholdt
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 19, 2022
Colonic Actinomycosis Mimicking Malignant Stenosing TumorsCasper Steenholdt, John Gade
Frontline Gastroenterology|February 23, 2023
Localised colonic AL amyloidosis: a rare manifestation of a rare diseaseCasper Steenholdt, Lene Buhl Riis
Ugeskrift for Laeger|November 29, 2014
[Prevention of infections in patients with inflammatory bowel disease during TNF inhibitor treatment]Katrine Risager Christensen, Casper Steenholdt
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 9, 2021
ReplyCasper Steenholdt, Jørn Brynskov, Peter Vilmann
The American Journal of Gastroenterology|January 5, 2022
Herpes Zoster Meningoencephalitis: A Novel, Rare, Potentially Fatal Side Effect to TofacitinibCasper Steenholdt, Lars Erik Kristensen, Jørn Brynskov
Scandinavian Journal of Gastroenterology|April 12, 2015
Clinical outcome of adalimumab therapy in patients with ulcerative colitis previously treated with infliximab: a Danish single-center cohort studyKatrine Risager Christensen, Casper Steenholdt, Jørn Brynskov
Pageof 9

Showing results (1-10 of 82) with videos related to

Sort By:
Pageof 9
The American Journal of Gastroenterology|December 1, 2015
Transient and Persistent Antibodies Against TNF-Inhibitors in IBDCasper Steenholdt
Danish Medical Journal|August 2, 2016
Personalized therapy with TNF-inhibitors in Crohn's disease: optimizing treatment outcomes by monitoring drug levels and anti-drug antibodiesCasper Steenholdt
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 21, 2018
Proactive and Reactive Therapeutic Drug Monitoring of Biologic Therapies in Inflammatory Bowel Disease Are Complementary, Not Mutually ExclusiveCasper Steenholdt
Danish Medical Journal|May 9, 2013
Use of infliximab and anti-infliximab antibody measurements to evaluate and optimize efficacy and safety of infliximab maintenance therapy in Crohn's diseaseCasper Steenholdt
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 19, 2022
Colonic Actinomycosis Mimicking Malignant Stenosing TumorsCasper Steenholdt, John Gade
Frontline Gastroenterology|February 23, 2023
Localised colonic AL amyloidosis: a rare manifestation of a rare diseaseCasper Steenholdt, Lene Buhl Riis
Ugeskrift for Laeger|November 29, 2014
[Prevention of infections in patients with inflammatory bowel disease during TNF inhibitor treatment]Katrine Risager Christensen, Casper Steenholdt
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 9, 2021
ReplyCasper Steenholdt, Jørn Brynskov, Peter Vilmann
The American Journal of Gastroenterology|January 5, 2022
Herpes Zoster Meningoencephalitis: A Novel, Rare, Potentially Fatal Side Effect to TofacitinibCasper Steenholdt, Lars Erik Kristensen, Jørn Brynskov
Scandinavian Journal of Gastroenterology|April 12, 2015
Clinical outcome of adalimumab therapy in patients with ulcerative colitis previously treated with infliximab: a Danish single-center cohort studyKatrine Risager Christensen, Casper Steenholdt, Jørn Brynskov
Pageof 9